(Q34498235)

2 August 2017

1 reference

title

Diabetic retinopathy: pathogenesis, clinical grading, management and future developments (English)

1 reference

2 August 2017

1 reference

T Peto

3

0 references

author name string

L Z Heng

1

1 reference

2 August 2017

O Comyn

2

1 reference

2 August 2017

C Tadros

4

1 reference

2 August 2017

E Ng

5

1 reference

2 August 2017

S Sivaprasad

6

1 reference

2 August 2017

P G Hykin

7

1 reference

2 August 2017

publication date

1 June 2013

1 reference

2 August 2017

1 reference

2 August 2017

volume

30

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

640-650

1 reference

Global prevalence and major risk factors of diabetic retinopathy

2 August 2017

cites work

1 reference

The pathogenesis of early retinal changes of diabetic retinopathy

21 January 2018

1 reference

The multifactorial nature of retinal vascular disease

21 January 2018

1 reference

Factors associated with visual acuity outcomes after vitrectomy for diabetic macular edema: diabetic retinopathy clinical research network

21 January 2018

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

21 January 2018

1 reference

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

Clinical review: The role of advanced glycation end products in progression and complications of diabetes

21 January 2018

1 reference

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

Long-term follow-up after tight control of blood pressure in type 2 diabetes.

21 January 2018

1 reference

Renal and retinal effects of enalapril and losartan in type 1 diabetes

21 January 2018

1 reference

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials

21 January 2018

1 reference

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial

21 January 2018

1 reference

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

21 January 2018

1 reference

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

21 January 2018

1 reference

Effects of medical therapies on retinopathy progression in type 2 diabetes

21 January 2018

1 reference

Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema

21 January 2018

1 reference

Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema.

21 January 2018

1 reference

Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation

21 January 2018

1 reference

Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema

21 January 2018

1 reference

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

21 January 2018

1 reference

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

21 January 2018

1 reference

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

21 January 2018

1 reference

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

21 January 2018

1 reference

A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.

21 January 2018

1 reference

A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3.

21 January 2018

1 reference

Macular perfusion determined by fundus fluorescein angiography at the 4-month time point in a prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (Bolt Study): Report 1.

21 January 2018

1 reference

The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema

21 January 2018

1 reference

Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study.

21 January 2018

1 reference

MMP9 is involved in glycation end-products induced increase of retinal vascular permeability in rats and the therapeutic effect of minocycline

21 January 2018

1 reference

Diabetic retinopathy and signaling mechanism for activation of matrix metalloproteinase-9

21 January 2018

1 reference

Pattern scan laser photocoagulation: safety and complications, experience after 1301 consecutive cases

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/DME.12089

1 reference

2 August 2017

1 reference